These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33887487)

  • 1. Feature Selection Methods for Protein Biomarker Discovery from Proteomics or Multiomics Data.
    Shi Z; Wen B; Gao Q; Zhang B
    Mol Cell Proteomics; 2021; 20():100083. PubMed ID: 33887487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study.
    Megger DA; Bracht T; Kohl M; Ahrens M; Naboulsi W; Weber F; Hoffmann AC; Stephan C; Kuhlmann K; Eisenacher M; Schlaak JF; Baba HA; Meyer HE; Sitek B
    Mol Cell Proteomics; 2013 Jul; 12(7):2006-20. PubMed ID: 23462207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust biomarker discovery for hepatocellular carcinoma from high-throughput data by multiple feature selection methods.
    Zhang Z; Liu ZP
    BMC Med Genomics; 2021 Aug; 14(Suppl 1):112. PubMed ID: 34433487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feature selection and nearest centroid classification for protein mass spectrometry.
    Levner I
    BMC Bioinformatics; 2005 Mar; 6():68. PubMed ID: 15788095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MultiAlign: a multiple LC-MS analysis tool for targeted omics analysis.
    LaMarche BL; Crowell KL; Jaitly N; Petyuk VA; Shah AR; Polpitiya AD; Sandoval JD; Kiebel GR; Monroe ME; Callister SJ; Metz TO; Anderson GA; Smith RD
    BMC Bioinformatics; 2013 Feb; 14():49. PubMed ID: 23398735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced peptide quantification using spectral count clustering and cluster abundance.
    Lee S; Kwon MS; Lee HJ; Paik YK; Tang H; Lee JK; Park T
    BMC Bioinformatics; 2011 Oct; 12():423. PubMed ID: 22034872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delineating protein biomarkers for gastric cancers: A catalogue of mass spectrometry-based markers and assessment of their suitability for targeted proteomics applications.
    Ramesh P; Nisar M; Neha ; Ammankallu S; Babu S; Nandakumar R; Abhinand CS; Prasad TSK; Codi JAK; Raju R
    J Proteomics; 2024 Aug; 306():105262. PubMed ID: 39047941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometry based biomarker discovery, verification, and validation--quality assurance and control of protein biomarker assays.
    Parker CE; Borchers CH
    Mol Oncol; 2014 Jun; 8(4):840-58. PubMed ID: 24713096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics for discovery of candidate colorectal cancer biomarkers.
    Alvarez-Chaver P; Otero-Estévez O; Páez de la Cadena M; Rodríguez-Berrocal FJ; Martínez-Zorzano VS
    World J Gastroenterol; 2014 Apr; 20(14):3804-24. PubMed ID: 24744574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INDEED: Integrated differential expression and differential network analysis of omic data for biomarker discovery.
    Zuo Y; Cui Y; Di Poto C; Varghese RS; Yu G; Li R; Ressom HW
    Methods; 2016 Dec; 111():12-20. PubMed ID: 27592383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia.
    Forshed J; Pernemalm M; Tan CS; Lindberg M; Kanter L; Pawitan Y; Lewensohn R; Stenke L; Lehtiö J
    J Proteome Res; 2008 Jun; 7(6):2332-41. PubMed ID: 18452325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
    Ma H; Chen G; Guo M
    Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometry protein expression profiles in colorectal cancer tissue associated with clinico-pathological features of disease.
    Liao CC; Ward N; Marsh S; Arulampalam T; Norton JD
    BMC Cancer; 2010 Aug; 10():410. PubMed ID: 20691062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-depth proteomic delineation of the colorectal cancer exoproteome: Mechanistic insight and identification of potential biomarkers.
    Karagiannis GS; Pavlou MP; Saraon P; Musrap N; Xie A; Batruch I; Prassas I; Dimitromanolakis A; Petraki C; Diamandis EP
    J Proteomics; 2014 May; 103():121-36. PubMed ID: 24681409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current advances in tumor proteomics and candidate biomarkers for hepatic cancer.
    Peng XQ; Wang F; Geng X; Zhang WM
    Expert Rev Proteomics; 2009 Oct; 6(5):551-61. PubMed ID: 19811076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using feature selection and Bayesian network identify cancer subtypes based on proteomic data.
    Wang Y; Gao X; Ru X; Sun P; Wang J
    J Proteomics; 2023 May; 280():104895. PubMed ID: 37024076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of biomarkers for screening hepatocellular carcinoma using global data mining and multiple reaction monitoring.
    Kim H; Kim K; Yu SJ; Jang ES; Yu J; Cho G; Yoon JH; Kim Y
    PLoS One; 2013; 8(5):e63468. PubMed ID: 23717429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies.
    Skates SJ; Gillette MA; LaBaer J; Carr SA; Anderson L; Liebler DC; Ransohoff D; Rifai N; Kondratovich M; Težak Ž; Mansfield E; Oberg AL; Wright I; Barnes G; Gail M; Mesri M; Kinsinger CR; Rodriguez H; Boja ES
    J Proteome Res; 2013 Dec; 12(12):5383-94. PubMed ID: 24063748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Tissue Proteomics Analysis Reveals Versican as Potential Biomarker for Early-Stage Hepatocellular Carcinoma.
    Naboulsi W; Megger DA; Bracht T; Kohl M; Turewicz M; Eisenacher M; Voss DM; Schlaak JF; Hoffmann AC; Weber F; Baba HA; Meyer HE; Sitek B
    J Proteome Res; 2016 Jan; 15(1):38-47. PubMed ID: 26626371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma.
    Xu X; Liu Z; Wang J; Xie H; Li J; Cao J; Zhou L; Zheng S
    Oncotarget; 2016 Mar; 7(12):13730-41. PubMed ID: 26883192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.